Lastly, patients with the most severe AD-tau Braak stage B3 had lower Aβ1-42 CSF (mean=119.75 pg/ml, SD=16.61) compared to those without AD-tau (mean=232.32, SD=42.38). The gene discussed is MAPT; the disease is Alzheimer disease.